SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-005438
Filing Date
2023-02-17
Accepted
2023-02-17 16:08:45
Documents
12
Period of Report
2022-07-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 39470
  Complete submission text file 0001493152-23-005438.txt   212882

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocx-20220715.xsd EX-101.SCH 3224
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocx-20220715_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocx-20220715_pre.xml EX-101.PRE 22358
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3575
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37648 | Film No.: 23642547
SIC: 2835 In Vitro & In Vivo Diagnostic Substances